Experts Discuss Role of Molecular Biomarkers in Diagnosis and Staging of Prostate Cancer
The ConfirmMDx test from MDx Health helps urologists rule out prostate cancer-free men from undergoing unnecessary repeat biopsies.
Read MorePosted by Judy O'Rourke | Apr 30, 2013 | Cancer, Molecular Diagnostics, Prostate, Research |
The ConfirmMDx test from MDx Health helps urologists rule out prostate cancer-free men from undergoing unnecessary repeat biopsies.
Read MorePosted by Judy O'Rourke | Apr 24, 2013 | Sexually Transmitted Diseases |
Today, the complexity of STDs requires more than a simple identification, but clinical labs rise to the occasion as technology fills in the gaps.
Read MorePosted by Judy O'Rourke | Mar 28, 2013 | Cancer, Prostate |
It is a 46-gene prognostic test that offers urologists a more accurate way to determine the aggressiveness of prostate cancer.
Read MorePosted by Judy O'Rourke | Mar 27, 2013 | Cancer, Miscellaneous, Pancreatic |
Industry experts discuss obstacles and successes.
Read MorePosted by Judy O'Rourke | Mar 27, 2013 | Cancer, Miscellaneous, Research |
Researchers say the collaborative effort and large-scale analysis are helping bridge the gap in understanding inherited factors that play a role in the disease.
Read More